Credit Suisse Group assumed coverage on shares of Axon Enterprise (NASDAQ:AXON – Get Rating) in a research note issued to investors on Monday, The Fly reports. The brokerage set an “outperform” rating and a $169.00 price target on the biotechnology company’s stock. Credit Suisse Group’s price target suggests a potential upside of 92.20% from the company’s current price.
Several other research firms have also issued reports on AXON. Northland Securities reduced their target price on Axon Enterprise from $220.00 to $180.00 in a report on Monday, February 28th. Zacks Investment Research raised Axon Enterprise from a “sell” rating to a “hold” rating in a report on Friday, March 4th. Needham & Company LLC reduced their price objective on Axon Enterprise from $250.00 to $170.00 and set a “buy” rating for the company in a report on Friday, February 25th. Robert W. Baird reissued a “buy” rating and set a $175.00 price objective on shares of Axon Enterprise in a report on Friday, February 25th. Finally, JPMorgan Chase & Co. raised Axon Enterprise from a “neutral” rating to an “overweight” rating and reduced their price objective for the company from $222.00 to $192.00 in a report on Friday, February 25th. One investment analyst has rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Axon Enterprise currently has a consensus rating of “Buy” and a consensus target price of $190.67.
AXON traded down $8.06 during midday trading on Monday, reaching $87.93. 26,215 shares of the company were exchanged, compared to its average volume of 458,940. The company’s fifty day moving average price is $127.34 and its 200 day moving average price is $144.66. The company has a market cap of $6.24 billion, a price-to-earnings ratio of -88.82 and a beta of 0.55. Axon Enterprise has a one year low of $94.80 and a one year high of $209.00.
In related news, CFO Jawad A. Ahsan sold 4,840 shares of the stock in a transaction on Tuesday, April 5th. The stock was sold at an average price of $141.17, for a total value of $683,262.80. Following the sale, the chief financial officer now owns 360,019 shares in the company, valued at $50,823,882.23. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 6.90% of the company’s stock.
Hedge funds have recently modified their holdings of the stock. Prospera Financial Services Inc purchased a new stake in shares of Axon Enterprise in the first quarter worth $27,000. Assetmark Inc. bought a new position in Axon Enterprise in the third quarter valued at $35,000. Retirement Planning Co of New England Inc. bought a new position in Axon Enterprise in the fourth quarter valued at $31,000. Tyler Stone Wealth Management bought a new position in Axon Enterprise in the fourth quarter valued at $32,000. Finally, Sageworth Trust Co of South Dakota bought a new position in Axon Enterprise in the fourth quarter valued at $37,000. Institutional investors own 72.06% of the company’s stock.
About Axon Enterprise (Get Rating)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, TASER, and Software and Sensors. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
- Get a free copy of the StockNews.com research report on Axon Enterprise (AXON)
- Johnson Outdoors Falls On Bleak Outlook
- Time to Buy These 3 Oversold Mid-Caps
- Institutional Support For Tyson Foods Is Growing
- Littelfuse Stock is Hitting on All Cylinders
- HCA Healthcare Stock is Ready to Climb Higher
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.